Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Medical Oncology (Northwood, London, England)|November 1, 2011
Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese populationJia-hong Chen, Hui-chan He, Fu-neng Jiang, et al.
Pathology Oncology Research : POR|April 19, 2011
Classical and alternative nuclear factor-κB pathways: a comparison among normal prostate, benign prostate hyperplasia and prostate cancerChao Cai, Fu-neng Jiang, Yu-xiang Liang, et al.
Biomed Research International|September 9, 2014
CC chemokine ligand 18 correlates with malignant progression of prostate cancerGuo Chen, Yu-xiang Liang, Jian-guo Zhu, et al.
Molecular Biology Reports|January 24, 2014
MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancerXiao-hui Ling, Zhao-dong Han, Dan Xia, et al.
FEBS Letters|June 20, 2012
MicroRNA-23b downregulates peroxiredoxin III in human prostate cancerHui-chan He, Jian-guo Zhu, Xi-bin Chen, et al.
International Journal of Clinical and Experimental Medicine|June 12, 2015
Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancerChao Cai, Jin-Yan Chen, Zhao-Dong Han, et al.
Medical Oncology (Northwood, London, England)|December 17, 2013
Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancerYa-Qiang Huang, Zhao-Dong Han, Yu-Xiang Liang, et al.
Medical Oncology (Northwood, London, England)|January 5, 2012
Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysisZhao-dong Han, Yan-qiong Zhang, Hui-chan He, et al.
BMC Cancer|June 19, 2012
SOXs in human prostate cancer: implication as progression and prognosis factorsWei-de Zhong, Guo-qiang Qin, Qi-shan Dai, et al.
International Journal of Cancer|January 3, 2014
MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1Zhuo-Yuan Lin, Ya-Qiang Huang, Yan-Qiong Zhang, et al.
Pageof 6